Literature DB >> 22896926

Gentamicin affects connexin 26 expression in the cochlear lateral wall.

P Hu1, R Lai, D Xie.   

Abstract

OBJECTIVES/HYPOTHESIS: Aminoglycosides may decrease the expression of some proteins participating in ion-exchange in the cochlear lateral wall. Connexin 26 expression in the lateral wall may play a role in acquired hearing loss by maintaining the endocochlear potential and potassium concentration in the endolymph. We examined the effects of gentamicin on the expression of connexin 26 to obtain a better understanding of aminoglycoside ototoxicity.
METHODS: We detected changes in connexin 26 protein and mRNA expression in the cochlear lateral wall using immunohistochemistry staining, western blotting, and real-time PCR in rats after administration of a single dose of gentamicin.
RESULTS: The expression of connexin 26 increased over time in type III fibrocytes after gentamicin administration. Elevated protein levels were detected 3 h after the single injection of gentamicin; while, mRNA levels increased after 24 h.
CONCLUSION: Connexin 26 plays an important role in the acute effects of high-dose gentamicin and is probably involved in the pathogenesis of ototoxic deafness.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22896926

Source DB:  PubMed          Journal:  B-ENT        ISSN: 1781-782X            Impact factor:   0.082


  2 in total

1.  Extracellular gentamicin reduces the activity of connexin hemichannels and interferes with purinergic Ca(2+) signaling in HeLa cells.

Authors:  Vania A Figueroa; Mauricio A Retamal; Luis A Cea; José D Salas; Aníbal A Vargas; Christian A Verdugo; Oscar Jara; Agustín D Martínez; Juan C Sáez
Journal:  Front Cell Neurosci       Date:  2014-09-04       Impact factor: 5.505

2.  Altered gene expression profile in a rat model of gentamicin-induced ototoxicity and nephrotoxicity, and the potential role of upregulated Ifi44 expression.

Authors:  Jun-Gen Hu; Yu Fu; Jian-Ju Xu; Xian-Ping Ding; Hui-Qi Xie; Jesse Li-Ling
Journal:  Mol Med Rep       Date:  2017-08-02       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.